IDH2 and central nervous system cancer: Additionally, a study by Grassian et al. observed increased oxidative TCA metabolism and reduced tumor growth rates in IDH-mutant glioma cells under hypoxic conditions, suggesting that IDH-mutant gliomas prefer a more oxygenated microenvironment for cell proliferation [17].